BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 20603408)

  • 1. 21 years of biologically effective dose.
    Fowler JF
    Br J Radiol; 2010 Jul; 83(991):554-68. PubMed ID: 20603408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity analysis of parameters in linear-quadratic radiobiologic modeling.
    Fowler JF
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1532-7. PubMed ID: 19306749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and neck cancers.
    Mohan R; Wu Q; Manning M; Schmidt-Ullrich R
    Int J Radiat Oncol Biol Phys; 2000 Feb; 46(3):619-30. PubMed ID: 10701741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of optimum dose per fraction for high LET radiations: implications for proton radiotherapy.
    Jones B; Dale RG
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1549-57. PubMed ID: 11121661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The radiobiology of prostate cancer including new aspects of fractionated radiotherapy.
    Fowler JF
    Acta Oncol; 2005; 44(3):265-76. PubMed ID: 16076699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in light ion radiation therapy.
    Brahme A
    Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):603-16. PubMed ID: 14751534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiobiology with heavy charged particles: a historical review.
    Skarsgard LD
    Phys Med; 1998 Jul; 14 Suppl 1():1-19. PubMed ID: 11542635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The optimal fraction size in high-dose-rate brachytherapy: dependency on tissue repair kinetics and low-dose rate.
    Sminia P; Schneider CJ; Fowler JF
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):844-9. PubMed ID: 11849810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiobiological modelling of dose-gradient effects in low dose rate, high dose rate and pulsed brachytherapy.
    Armpilia C; Dale RG; Sandilos P; Vlachos L
    Phys Med Biol; 2006 Sep; 51(17):4399-411. PubMed ID: 16912389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of a large number of clinical studies for breast cancer radiotherapy: estimation of radiobiological parameters for treatment planning.
    Guerrero M; Li XA
    Phys Med Biol; 2003 Oct; 48(20):3307-26. PubMed ID: 14620060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modelling carcinogenesis after radiotherapy using Poisson statistics: implications for IMRT, protons and ions.
    Jones B
    J Radiol Prot; 2009 Jun; 29(2A):A143-57. PubMed ID: 19454805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there an optimum overall time for head and neck radiotherapy? A review, with new modelling.
    Fowler JF
    Clin Oncol (R Coll Radiol); 2007 Feb; 19(1):8-22. PubMed ID: 17305251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of currently used radiobiological parameters with local control and acute and late mucosal toxicity in randomised studies of altered fractionation for locally advanced head and neck cancer.
    Hartley A; Sanghera P; Kazi W; Mehanna H; McConkey C; Glaholm J; Fowler J
    Clin Oncol (R Coll Radiol); 2011 Feb; 23(1):29-33. PubMed ID: 20829006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical radiobiology of proton therapy: modeling of RBE.
    Jones B
    Acta Oncol; 2017 Nov; 56(11):1374-1378. PubMed ID: 28820311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biologically effective dose distribution based on the linear quadratic model and its clinical relevance.
    Lee SP; Leu MY; Smathers JB; McBride WH; Parker RG; Withers HR
    Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):375-89. PubMed ID: 7673025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute radiation reactions in oral and pharyngeal mucosa: tolerable levels in altered fractionation schedules.
    Fowler JF; Harari PM; Leborgne F; Leborgne JH
    Radiother Oncol; 2003 Nov; 69(2):161-8. PubMed ID: 14643953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of intensity-modulated radiotherapy plans based on the equivalent uniform dose.
    Wu Q; Mohan R; Niemierko A; Schmidt-Ullrich R
    Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):224-35. PubMed ID: 11777642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generalized Multi-Hit Model of Radiation-Induced Cell Survival with a Closed-Form Solution: An Alternative Method for Determining Isoeffect Doses in Practical Radiotherapy.
    Zhao L; Chen X; Tian J; Shang Y; Mi D; Sun Y
    Radiat Res; 2020 Apr; 193(4):359-371. PubMed ID: 32031917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further radiobiologic modeling of palliative radiotherapy: use of virtual trials.
    Jones B; Dale RG
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):221-9. PubMed ID: 17707276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential for sparing of parotids and escalation of biologically effective dose with intensity-modulated radiation treatments of head and neck cancers: a treatment design study.
    Wu Q; Manning M; Schmidt-Ullrich R; Mohan R
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):195-205. PubMed ID: 10656393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.